70 related articles for article (PubMed ID: 2547929)
1. Cyclic guanosine 3',5' monophosphate mediates the inhibitory effect of atrial natriuretic factor in adrenergic, neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Marchand GR; Trachte GJ
J Pharmacol Exp Ther; 1989 Aug; 250(2):428-32. PubMed ID: 2547929
[TBL] [Abstract][Full Text] [Related]
2. Neuromodulatory effects of atrial natriuretic factor are independent of guanylate cyclase in adrenergic neuronal pheochromocytoma cells.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1990 Nov; 255(2):497-503. PubMed ID: 1978729
[TBL] [Abstract][Full Text] [Related]
3. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
5. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP as mediator and biological marker of atrial natriuretic factor.
Hamet P; Tremblay J; Pang SC; Skuherska R; Schiffrin EL; Garcia R; Cantin M; Genest J; Palmour R; Ervin FR
J Hypertens Suppl; 1986 Jun; 4(2):S49-56. PubMed ID: 2873213
[TBL] [Abstract][Full Text] [Related]
7. Effects of atrial natriuretic peptide and sodium nitroprusside on epidermal growth factor-stimulated wound repair in rabbit corneal epithelial cells.
Zhang Y; Islam M; Akhtar RA
Curr Eye Res; 2000 Sep; 21(3):748-56. PubMed ID: 11120563
[TBL] [Abstract][Full Text] [Related]
8. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles.
Ding KH; Abdel-Latif AA
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582
[TBL] [Abstract][Full Text] [Related]
9. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats.
Nonoguchi H; Knepper MA; Manganiello VC
J Clin Invest; 1987 Feb; 79(2):500-7. PubMed ID: 3027127
[TBL] [Abstract][Full Text] [Related]
10. Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation.
White RE; Lee AB; Shcherbatko AD; Lincoln TM; Schonbrunn A; Armstrong DL
Nature; 1993 Jan; 361(6409):263-6. PubMed ID: 7678699
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor (ANF) inhibits arginine vasopressin-stimulated Ca2+ fluxes and cell contraction in vascular smooth muscle cells.
Meyer-Lehnert H; Tsai P; Schrier RW
Klin Wochenschr; 1987; 65 Suppl 8():115-21. PubMed ID: 3037182
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
Leitman DC; Murad F
Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
[TBL] [Abstract][Full Text] [Related]
13. Effect of atrial natriuretic factor and fate of cyclic-guanosine-monophosphate in the rat kidney.
Syrén ML
Acta Physiol Scand; 1997 May; 160(1):1-7. PubMed ID: 9179304
[TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide stimulates catecholamine synthesis through the accumulation of cyclic GMP in cultured bovine adrenal medullary cells.
Tsutsui M; Yanagihara N; Minami K; Kobayashi H; Nakashima Y; Kuroiwa A; Izumi F
J Pharmacol Exp Ther; 1994 Feb; 268(2):584-9. PubMed ID: 7906732
[TBL] [Abstract][Full Text] [Related]
15. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway.
Babiker FA; De Windt LJ; van Eickels M; Thijssen V; Bronsaer RJ; Grohé C; van Bilsen M; Doevendans PA
Circulation; 2004 Jan; 109(2):269-76. PubMed ID: 14718400
[TBL] [Abstract][Full Text] [Related]
16. Effect of synthetic atrial natriuretic peptide on rat renal juxtaglomerular cells.
Kurtz A; Della Bruna R; Pfeilschifter J; Bauer C
J Hypertens Suppl; 1986 Jun; 4(2):S57-60. PubMed ID: 3014096
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts.
Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS
J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide inhibits evoked catecholamine release by altering sensitivity to calcium.
Kanwal S; Elmquist BJ; Trachte GJ
J Pharmacol Exp Ther; 1997 Nov; 283(2):426-33. PubMed ID: 9353354
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
Trachte GJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic factor and cyclic guanosine 3',5'-monophosphate in vascular smooth muscle.
Sato M; Abe K; Takeuchi K; Yasujima M; Omata K; Hiwatari M; Kasai Y; Tanno M; Kohzuki M; Kudo K
Hypertension; 1986 Sep; 8(9):762-71. PubMed ID: 3017853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
